Clinical Trial Update: Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Nobelpharma evaluated the efficacy and safety of a low-dose oral contraceptive pill for dysmenorrhea and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Low-dose oral contraceptive pill

Snippet

Sponsor: Nobelpharma | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED